1. Home
  2. PJT vs LGND Comparison

PJT vs LGND Comparison

Compare PJT & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PJT
  • LGND
  • Stock Information
  • Founded
  • PJT 2014
  • LGND 1987
  • Country
  • PJT United States
  • LGND United States
  • Employees
  • PJT N/A
  • LGND 68
  • Industry
  • PJT Investment Managers
  • LGND Biotechnology: Pharmaceutical Preparations
  • Sector
  • PJT Finance
  • LGND Health Care
  • Exchange
  • PJT Nasdaq
  • LGND Nasdaq
  • Market Cap
  • PJT 3.9B
  • LGND 3.2B
  • IPO Year
  • PJT N/A
  • LGND 1992
  • Fundamental
  • Price
  • PJT $166.26
  • LGND $201.87
  • Analyst Decision
  • PJT Hold
  • LGND Strong Buy
  • Analyst Count
  • PJT 3
  • LGND 8
  • Target Price
  • PJT $193.50
  • LGND $144.71
  • AVG Volume (30 Days)
  • PJT 243.6K
  • LGND 139.7K
  • Earning Date
  • PJT 11-04-2025
  • LGND 08-05-2025
  • Dividend Yield
  • PJT 0.60%
  • LGND N/A
  • EPS Growth
  • PJT 72.84
  • LGND N/A
  • EPS
  • PJT 6.53
  • LGND N/A
  • Revenue
  • PJT $1,657,789,000.00
  • LGND $181,488,000.00
  • Revenue This Year
  • PJT $11.42
  • LGND $18.41
  • Revenue Next Year
  • PJT $12.18
  • LGND $18.87
  • P/E Ratio
  • PJT $25.52
  • LGND N/A
  • Revenue Growth
  • PJT 23.30
  • LGND 53.40
  • 52 Week Low
  • PJT $119.76
  • LGND $81.74
  • 52 Week High
  • PJT $190.28
  • LGND $129.90
  • Technical
  • Relative Strength Index (RSI)
  • PJT 41.54
  • LGND 60.86
  • Support Level
  • PJT $166.52
  • LGND $201.50
  • Resistance Level
  • PJT $172.97
  • LGND $212.49
  • Average True Range (ATR)
  • PJT 6.03
  • LGND 8.11
  • MACD
  • PJT -0.04
  • LGND 0.34
  • Stochastic Oscillator
  • PJT 29.95
  • LGND 63.34

About PJT PJT Partners Inc.

PJT Partners Inc is an advisory-focused investment bank that offers a portfolio of advisory services designed to help its clients achieve their strategic objectives. The company delivers a range of strategic advisory, capital markets advisory, restructuring and special situations, and shareholder advisory services to corporations, financial sponsors, institutional investors, and governments around the world. It also provides private fund advisory and fundraising services for alternative investment strategies, including private equity, real estate, hedge funds, and private credit. The company generates its revenue from advisory fees, placement services and others. Geographically, It generates a majority of its revenue from the United States.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: